FDA Inspection 1272074 — Hainan Simcere Pharmaceutical Co., Ltd.

Hainan Simcere Pharmaceutical Co., Ltd. — FEI 3015251693

The FDA completed an inspection of Hainan Simcere Pharmaceutical Co., Ltd. on Apr 29, 2025 in Haikou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Apr 29, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Haikou (China)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.